Phase 11 Open-Label, Controlled Randomized, Multi-centre Study to Evaluate the Efficacy & Safety of Pertuzumab (Omnitarg) a Recombinant Humanized Antibody Against HER2, in Combination with Carbo Based Standard Chemo vs Carbo Standard Chemo.

Project: Research

Participants

Colleges, School and Institutes

Short titlePhase 11 Open-Label, Controlled Randomized, Multi-centre Study to Evaluate the Efficacy & Safety of Pertuzumab (Omnitarg) a Recombinant Humanized Antibody Against HER2, in Combination with Carbo Based Standard Chemo vs Carbo Standard Chemo.
StatusFinished
Effective start/end date15/12/0514/02/09